USA

Fluidigm

Now known as Standard BioTools Inc, Fluidigm’s technologies and products based on microfluidics and mass cytometry enable the exploration and analysis of individual cells, as well as the industrial application of genomics. Listed on NASDAQ in 2011.

Fluidigm Read More »

Lonza

A large-scale cell culture manufacturing site for the production of monoclonal antibodies and recombinant proteins. Acquired by Lonza Group in 2008.

Lonza Read More »

Moderna

Pioneers the discovery and development of messenger RNA (mRNA) therapeutics and vaccines, an entirely new class of medicines that directs the body’s cells to produce intracellular or secreted proteins that can have a therapeutic or preventive benefit for both patients and healthy individuals. Listed on NASDAQ in 2018.

Moderna Read More »

Nuvation Bio

Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates to improve the quality of life and survival for people with cancer.

Nuvation Bio Read More »

Aetion

Aetion is a health care technology company that delivers real-world evidence for biopharma companies, payers, regulators, and HTA agencies. The Aetion Evidence Platform® analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on safety, effectiveness, and value across the product life cycle.

Aetion Read More »

Joby Aviation

Joby Aviation, Inc. (NYSE:JOBY) is a California-based transportation company developing an all-electric, vertical take-off and landing aircraft which it intends to operate as part of a fast, quiet, and convenient service in cities around the world.

Joby Aviation Read More »